Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
A case-control study demonstrated strong association of p.R4810K with moyamoya disease in East Asian populations (251 cases and 707 controls) with an odds ratio of 111.8 (P = 10(-119)).
|
21799892 |
2011 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
A polymorphism (R4810K) in the Ring Finger Protein 213 (RNF213) gene, at chromosome 17q25.3, is the strongest genetic susceptibility factor for MMD in East Asian populations.
|
31650369 |
2019 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Because of a family history of Moyamoya disease (MMD), genetic analysis was performed, and revealed that this patient was homozygous for RNF213 p.Arg4810Lys.
|
28962888 |
2018 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo.
|
26126547 |
2015 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
|
29567577 |
2018 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Due to a family history of moyamoya disease, a genetic investigation was performed and revealed RNF213 p.R4810K homozygous variant.
|
31806452 |
2020 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K.
|
25547042 |
2015 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.
|
27365075 |
2016 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Further studies are needed to clarify the relationship between the rs112735431 polymorphism of the RNF213 and hypertension in patients with MMD.
|
28320162 |
2017 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Genotyping of the p.R4810K missense variant is useful for identifying individuals with an elevated risk for steno-occlusive intracranial arterial diseases in the family members of patients with moyamoya disease.
|
28506590 |
2017 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
In East Asian countries, moyamoya is strongly associated to the R4810K variant in the RNF213 gene that encodes for a protein containing a RING-finger and two AAA+ domains.
|
28635953 |
2017 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Many non-p.R</span>4810K</span> rare variants of RNF213 have been identified in white moyamoya disease patients, although the ethnic mutations have not been investigated in this population.
|
27736983 |
2016 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
MDR analysis failed to detect any significant interaction among these five loci in the occurrence of M</span>MD (P>0.05), but the combination of three loci (rs112735431 in RNF213, rs3828610 in PDGFRB, rs3025058 in MMP-3) could have the maximum testing accuracy (57.29%) and cross-validation consistency (10/10).
|
23769926 |
2013 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Moreover, c.14</span>429G>A</span> (p.R</span</span>>4810K</span>) genotypes occurred more frequently in patients with a family history of MMD.
|
26430847 |
2016 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
On the other hand, a common missense mutation [NM_001256071.2:c.14429G>A (p.Arg4810Lys)] related to MMD in exon 60 of RNF213 was also identified by Sanger sequencing.
|
31347299 |
2019 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our case-control study and meta-analysis both provide evidence of an association between the rs112735431(c.14576G>A) polymorphism in the RNF213 gene and MMD risk.
|
27515544 |
2016 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Our meta-analysis strengthens RNF213 rs112735431 is closely associated with the increased risk of MMD in Japanese, and the screening combined with rs112735431 and rs138130613may improve the detection rate for MMD in China.
|
26847828 |
2016 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Recent studies have shown that a proportion of East Asian (EAS) patients with MMS possess the p.R4810K variant of RNF213 (rs112735431), the foremost susceptibility variant among EAS patients with MMD.
|
30922903 |
2019 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
RNF213 R4810K reduced angiogenic activities of iPSECs from patients with MMD, suggesting that it is a promising in vitro model for MMD.
|
23850618 |
2013 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
RNF213 p.R4810K was identified as a susceptibility variant for moyamoya disease in Asia and non-moyamoya intracranial artery stenosis/occlusion disease in Japan and Korea recently.
|
29165136 |
2017 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
RNF213 p.R4810K was associated with MMD, ICASO, and quasi-MMD in different genetic models.
|
29752070 |
2018 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.
|
28414759 |
2017 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Significantly higher frequencies of the A allele and G/A genotype of p.R4810K</span> were observed in MMD patients compared with controls (χ<sup>2</sup> = 104.166, p < 0.000).
|
27128593 |
2017 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
Sixteen of 46 variants were polymorphisms with minor allele frequency >1%, and, after conditioning on the p.R4810K genotype, were not associated with MMD.
|
25964206 |
2015 |
Moyamoya Disease
|
|
0.100 |
GeneticVariation
|
BEFREE |
The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality.
|
23994138 |
2013 |